Literature DB >> 11544883

[Quantitative studies of lysozyme and phosphohexose isomerase enzymes in mixed saliva in oral squamous epithelial carcinoma].

P Meyer1, T Zechel.   

Abstract

BACKGROUND: In connection with quantitative sialochemical investigations in mixed saliva from patients with oral squamous cell carcinoma (OPC), the enzymes phosphohexoseisomerase (PHI) and lysozyme (Ly) were investigated. The glycolytic enzyme PHI recently became interesting as a tumor marker. Lysozyme represents the main enzyme of the nonspecific salivary immune defense. PATIENTS AND METHODS: The enzyme concentrations were specified in 25 men with OPC and in a control group of 20 healthy men of comparable age. RESULTS AND
CONCLUSIONS: In the mixed saliva of the OPC patients, the PHI concentration was significantly diminished according to the Mann-Whitney-Wilcoxon test compared to the control group (p = 0.022). The lysozyme concentration, however, significantly increased (p = 0.011). These results prove serious sialochemical alterations in mixed saliva of OPC patients. They extend our former studies on kallikrein in glandular mixed saliva, but at present only have a descriptive character. Further pathobiochemical investigations on this subject should be carried out.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544883     DOI: 10.1007/s001060170058

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  2 in total

1.  Comparison of N-linked Glycoproteins in Human Whole Saliva, Parotid, Submandibular, and Sublingual Glandular Secretions Identified using Hydrazide Chemistry and Mass Spectrometry.

Authors:  Prasanna Ramachandran; Pinmanee Boontheung; Eric Pang; Weihong Yan; David T Wong; Joseph A Loo
Journal:  Clin Proteomics       Date:  2008-12       Impact factor: 3.988

Review 2.  Comparative human salivary and plasma proteomes.

Authors:  J A Loo; W Yan; P Ramachandran; D T Wong
Journal:  J Dent Res       Date:  2010-08-25       Impact factor: 6.116

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.